End-Stage Renal Disease
Part of NephTimes
Sarah Tolson gives tips on how nephrology practices can improve billing processes to avoid lost revenue. Fibrate use is associated with higher incidence of CKD but lower risk for ESKD and mortality, a study found. Pain coping skills training demonstrated benefits for patients on maintenance hemodialysis in a randomized clinical trial. Hemodialysis patients reporting shorter sleep or problems sleeping had a higher mortality risk in an observational study. The American Society of Nephrology (ASN) will create a Centers of Excellence in Home Dialysis pilot program. Sarah Tolson reviews how changes to reimbursement for phosphate binders have affected dialysis programs. A study compared the impact of conservative management of CKD vs transition to dialysis on risk for cognitive dysfunction. What were the effects of moving calcimimetics from the TDAPA to an increased bundled payment? Is coprescription of gabapentinoids with other psychoactive medications associated with altered mental status and falls? Sarah Tolson highlights the concerns and challenges dialysis programs face under the 2025 ESRD PPS requirements. A study compared CV risks and fracture prevention benefits of denosumab versus oral bisphosphonates in patients on dialysis. Research examined the role of serum phosphate in CKD-associated pruritus and the efficacy of treatment with difelikefalin. A review compared the efficacy and safety of incremental peritoneal dialysis with standard full-dose peritoneal dialysis. The American Kidney Fund is providing emergency financial aid to patients impacted by the California wildfires. A study identified modifiable dialysis-related factors associated with fatigue and dialysis recovery time. Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS. A study examined the impact of hemodiafiltration versus hemodialysis in patients with end-stage renal disease. The FDA granted Breakthrough Device Designation to a device to treat chronic systemic inflammation in hemodialysis patients. Baxter International has resumed all peritoneal dialysis solutions manufacturing lines at its hurricane-damaged NC facility. A study documented findings on vitamin D and metabolic bone disease in children requiring prolonged CKRT.